CANF
Can-Fite BioPharma Ltd.
$3.25
-0.23 (-6.61%)
At close · Jul 8
Market Cap
$7.01M
Shares
2,142,547
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$405K
-39.9%
FY2025
Net Income
-$9.83M
-24.7%
FY2025
Operating Margin
-2456.79%
-1250.6pp
FY2025
Diluted EPS
-$5.97
FY2025
Operating Cash Flow
-$8.95M
-17.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| $405K | $674K | $743K | $810K | $853K | $763K | $2.03M | — | — | |
| — | — | — | -$77K | $227K | -$303K | — | — | — | |
| $6.69M | $5.76M | $5.98M | $7.76M | $9.85M | $11.95M | $10.98M | $6.08M | $5.11M | |
| $3.66M | $3.05M | $2.96M | $3.14M | $3.85M | $2.95M | $3.06M | $3.16M | $2.87M | |
| — | — | — | $263K | — | — | — | — | — | |
| $24K | — | — | $14K | $14K | $12K | — | — | — | |
| $10.36M | $8.8M | — | — | — | — | — | — | — | |
| -$9.95M | -$8.13M | -$8.2M | -$10.1M | -$12.84M | -$14.14M | -$12.01M | — | — | |
| -2456.79% | -1206.23% | -1102.96% | -1246.42% | -1505.51% | -1853.08% | -590.9% | — | — | |
| -$9.93M | — | — | -$10.08M | -$12.83M | -$14.13M | — | — | — | |
| $284K | -$291K | — | — | — | — | — | — | — | |
| $122K | $250K | $561K | -$77K | $227K | -$304K | -$618K | — | — | |
| — | — | — | $162K | $162K | $11K | $769K | — | — | |
| -$9.83M | -$7.88M | -$7.63M | -$10.17M | -$12.62M | -$14.44M | -$12.63M | — | — | |
| — | — | — | — | — | — | $4000 | — | — | |
| -$9.83M | -$7.88M | -$7.63M | -$10.17M | -$12.62M | -$14.44M | -$12.63M | — | -$6.43M | |
| -2426.67% | -1169.14% | -1027.46% | -1255.93% | -1478.9% | -1892.92% | -621.31% | — | — | |
| — | -$7.88M | — | — | — | — | -$12.63M | — | — | |
| USD/shares | -$5.97 | $0.00 | -$0.20 | -$0.20 | — | — | — | — | — |
| USD/shares | -$5.97 | $0.00 | -$0.20 | -$0.20 | — | — | — | — | — |
| shares | 1.65M | 108.8M | 63.92M | 40.79M | 2.77M | 1.79M | 429.55K | — | — |
| shares | 1.65M | 108.8M | 63.92M | 40.79M | 2.77M | 1.79M | 429.55K | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2023: $7.77M in dividends.